Effect of 0.02% and 0.01% atropine on astigmatism: a two-year clinical trial.

Wang, Ming; Cui, Can; Sui, Yao; Yu, Shi-Ao; Ma, Jing-Xue; Fu, Ai-Cun

Wang, Ming; Cui, Can; Sui, Yao; Yu, Shi-Ao; Ma, Jing-Xue; Fu, Ai-Cun.

Afiliación

Wang M; The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe road, Zhengzhou, 450000, China.
Cui C; The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, China.
Sui Y; The Second Hospital of Hebei Medical University, Heping West Road No. 215, Shi Jiazhuang, 050000, China.
Yu SA; The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe road, Zhengzhou, 450000, China.
Ma JX; The Second Hospital of Hebei Medical University, Heping West Road No. 215, Shi Jiazhuang, 050000, China. majingxue2003@163.com.
Fu AC; The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe road, Zhengzhou, 450000, China. fuaicun2019@qq.com.

BMC Ophthalmol ; 22(1): 161, 2022 Apr 07.

Article en En | MEDLINE | ID: mdl-35392841

Asunto(s)

Astigmatismo; Enfermedades de la Córnea; Astigmatismo/tratamiento farmacológico; Atropina/uso terapéutico; Niño; Estudios de Cohortes; Córnea; Humanos; Soluciones Oftálmicas; Estudios Prospectivos; Refracción Ocular

Palabras clave

Astigmatism; Atropine; Children; Low-concentration; Myopia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Astigmatismo / Enfermedades de la Córnea Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: BMC Ophthalmol Asunto de la revista: OFTALMOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google